期刊文献+

恶性肿瘤术中组织间永久植入^(125)I粒子放疗 被引量:3

Tumor intra-operative interstitial permanent implantation radiation ther apy with ^(125)I seeds
暂未订购
导出
摘要 125I粒子组织间永久植入治疗恶性肿瘤,具有病变组织接受内辐射剂量大、有效抑制或破坏肿瘤组织、操作简便、无并发症等优点。国外主要通过介导植入法广泛用于前列腺癌的治疗。 The therapy of tumor that p ermanent implantion with 125 I seeds could supplied bigger radiation doses for fault tissue to suppress o r destroy tissue of tumor effectively.It is a simple and safety treatment.The 125 I seeds implantation by guided method mostly is widely used treating prostat e cancer abroad today.
作者 查金顺
出处 《国外医学(放射医学核医学分册)》 2002年第5期227-230,共4页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词 恶性肿瘤 组织间放疗 粒子植入术 碘125 放射疗法 radiation therapy iodine-125 interstiti al permanent implantation with seeds treatment of tumor
  • 相关文献

参考文献11

  • 1Martinez-Monge R, Nag S, Nieroda CA, et al. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastic to the liver[J]. Cancer, 1999, 85: 1218-1224.
  • 2Cormack RA, Kooy H, Tempany CM, et al. Aclinical method for real-time dosimeric guidance of transperineal ~(125)I prostate implants using interventional magnetic resonance imaging [J]. Int J Radiat Oncol Biol Phys, 2000, 46(1): 207-214.
  • 3岳麓.^(125)I籽源组织间照射在肿瘤治疗中的应用[J].国外医学(放射医学核医学分册),2001,25(1):23-26. 被引量:51
  • 4Weaver K, Smith V, Lewis JD, et al. A CT-based computerized treatment planning system for I-125 stereotactic brain implants[J]. Int J Radiat Oncol Biol Phys, 1990, 18(2): 445-454.
  • 5Bauer-Kirpes B, Sturm V, Schlegel W, et al. Computerized optimization of ~(125)I implants in brain tumors[J]: Int J Radiat Oncol Biol Phys, 1988, 14(5): 1013-1023.
  • 6Stock RG, Stone NN, Iannuzzi C. Sexual potency following interactive ultrasound-guided braehytherapy for prostate cancer[J]. Int J Radiat Oncol Biol Phys, 1996, 35(2): 267-272.
  • 7Merrick GS, Butter WM, Dorsey AT, et al. Seed fixity in the prostate/Reriprostic region following brachytherapy[J]. Int J Radiat Oncol Biol Phys, 2000, 46(1): 215-240.
  • 8Lee WR, McQuellon RP, Harris-Henderson K, et al. A prelininary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer[J]. Int J Radiat Oncol Biol Phys, 2000, 46(1): 77-81.
  • 9Kumar PP, Patil AA, Syh HW, et al. Role of brachytherapy in the management of the skull base meningioma. Treatment of skull base meningiomas[J]. Cancer, 1993, 71(11): 3726-3731.
  • 10Meli JA, Dicker CS, Schulz RJ. Computer applications to radioactive-seed: brain-tumor implants[J]. Comput Med Imaging Graph, 1989, 13(3): 269-274.

二级参考文献19

  • 1Lazarescu GR, Battista JJ. Analysis of the radiobiolo gy of Ytterbium-169 and Iodine-125 permanent brachytherapy implants[j]. Phys Med Biol, 1997,42:1727-1736.
  • 2Ling CC. Permanent implams using Au-198, Pd-103and I-125: Radiobiological considerations based on the linear quadratic model [J]. Int J Radiat Oncol Biol Phys, 1992,23:81-87.
  • 3Kim JH, Hilaris BS. Iodinc-125 sourcc in interstitial tumor therapy[J]. Radiology, 1975,123:163-169.
  • 4Anderson LL, Kuan HM, Ding IY. Clinical dosimetry with I-125 [A]. In Gorge [ed]. Modern interstitial and intracavitary radation cancer management [C].New York : Masson Publishing, 1981.
  • 5Williamson JF. Physics of brachythcrapy[A]. Perez CA, Brady LW[ed]. Principles and practice of radiation oncology [C]. Third Edition, Philadelphia: Lippincott -Raven, 1997.
  • 6Nath R, Anderson LL, Meli JA, et al. Code of practice for brachytherapy physics: Report of the AAPM radation therpy committee task group NO. 56[J]. Med Phys, 1997,24:1557-1579.
  • 7Wu A, Zwicker D, Sternick ES. Tumor dose specification of I-125 seed implants[J]. Med Phys, 1985,12:27-31.
  • 8Chen Y, Stanton RE, Holst RJ, et al. Treatment planning for prostate implant with loose seeds [J].Med Phys,1997, 24:1141-1145.
  • 9Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachtherapy sources:Recommendations of the AAPM radiation therapy committee task group NO. 43[J]. Med Phys,1995, 22:209-233.
  • 10Williamson JF, Courscy BM, DeWerd LA, et al.Guidence to users of Nycomed Amersham and North American Scientific, Inc, I-125 interstitial sources:Dosimetry and calibration changes: Recommendations of the American Association of physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on low-energy[J]. Med Phys, 1999,26:570-573.

共引文献50

同被引文献7

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部